|

Tamoxifen, Letrozole, Anastrozole, or Exemestane Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Endocrine Therapy

Pipeline

Phase 3: 1

Top Sponsors

  • University of Virginia1

Indications

  • Breast Cancer Female1
  • Breast Cancer1
  • Cancer1

Charlottesville, Virginia1 trial

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

University of Virginia

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.